KitePod by Venture Kites: Exploring Tomorrow's Innovations
In this episode of KitePod, we delve into the fascinating world of Immunito AI, a Bengaluru-based TechBio startup that's transforming the landscape of antibody therapy. Founded by the visionary duo Dr. Aridni Shah and Trisha Chatterjee, Immunito AI leverages artificial intelligence to design cutting-edge antibodies tailored for precise and effective treatments. Discover how their innovative platforms, imDESIGN and imRANK, are redefining traditional drug discovery by reducing development timelines by 60% and significantly cutting costs. From addressing challenges in biotechnology to creating groundbreaking solutions for diseases like cancer and autoimmune disorders, Immunito AI is a beacon of innovation in the biotech industry. Join us as we explore their journey, challenges, and triumphs, including their $1 million seed funding, global recognitions, and ambitious mission to make antibody therapies accessible worldwide. Tune in to learn how AI and biotechnology are merging to create a future of faster, smarter, and more efficient medical solutions. 🔍 Check out the full article on Venture Kites: https://venturekites.com/immunito-ai-antibodies-with-a-side-of-artificial-intelligence/ 🌍 Discover more startup stories at Venture Kites! https://venturekites.com/ 🤝 Proudly crafted in collaboration with DORK Company. https://dorkcompany.com/
5 episodes
Comments
0Be the first to comment
Sign up now and become a member of the KitePod by Venture Kites: Exploring Tomorrow's Innovations community!